Envoy Medical, Inc. (Nasdaq: COCH) is a Minnesota-based medical device company focused on hearing health, best known for its Esteem fully implanted hearing device. The company became publicly traded through its business combination with Anzu Special Acquisition Corp I, a blank-check vehicle sponsored by Anzu Partners, which completed its IPO in 2021. The merger closed in 2023, bringing Envoy Medical into the public markets within the medical devices and hearing health sector. On August 31, 2026, the company filed a DEF 14A definitive proxy statement with the SEC, accession number 0001213900-26-095756, reflecting its continued obligations as a reporting public company. Visit SpacDesk and sign up for a full data subscription to access complete filing histories, sponsor profiles, and deal analytics on COCH and hundreds of other SPAC-linked companies.